Ispire Technology (ISPR) Q4 2026 earnings review
Growth returns on ODM ramp, but margins and cash timeline break
Ispire reported Q4 revenue of $26.7 million, growing 32.5% year-over-year and 43% sequentially, decisively ending a three-quarter string of sharp declines. However, the top-line beat did not carry through to profitability: reported gross margin compressed to 6.3%, or 8.0% clean of inventory impairments, and total credit loss expense remained high at $9.2 million. Operating cash burn for the full year narrowed to $569,000, an improvement of $6.8 million.
⚖️ Verdict: 🔴 Bearish
The case is worse — a bearish verdict — because the company withdrew its target to become cash-flow positive in the second half of 2026. Management cited new capital requirements for the Malaysia manufacturing facility, pushing the timeline out just as unit economics hit a low. While the pivot to nicotine ODM is successfully driving top-line growth and core operating expenses are structurally lighter, the cost to scale the new footprint and the lingering bad debt from the cannabis exit are consuming all the leverage.
What the print did not settle is when the stated 25% tariff advantage of the Malaysian facility will actually translate into margin recovery. Next quarter's gross margin and capital expenditure figures give the reading — margins must clear the low double digits to prove the factory is a structural advantage rather than a cash sink.
🐂 Bull Case
Top-Line Reversal Validates the Pivot
After three quarters of steep double-digit declines, the top line decisively broke trend in Q4. Revenue grew 32.8% year-over-year to $26.7 million, marking a 43% sequential acceleration. The return to growth indicates the most painful part of abandoning the legacy U.S. cannabis hardware market is over, and the replacement volume from the new nicotine Vapor ODM channel is finally arriving at scale.
The number to watch is whether this pace holds as the Vapor ODM platform expands beyond mid-sized brands to larger targets in 2027. If it does, the revenue base will quickly outgrow the drag of the old business.
Core Operating Leverage
The company's cost discipline is yielding real operating leverage underneath the noise. While total operating expenses fell 11.1% year-over-year, stripping out the heavy $9.2 million credit loss expense reveals a leaner core structure. Core operating expenses ran at just $6.0 million in Q4, representing 22.5% of revenue, down significantly from 42.3% of revenue a year ago.
If management can stop writing off bad debt, this leaner footprint is engineered to pass a large portion of the new ODM revenue directly through to the bottom line.
🐻 Bear Case
The Cash-Flow Target Is Delayed
Management framed this quarter as an "important inflection point" for the turnaround, but the numbers cut against that narrative on the cash flow timeline. Last quarter, the company set a firm target to become cash-flow positive in the second half of calendar year 2026. This release quietly withdraws that target, citing new investments made in the Malaysia manufacturing facility during Q1 FY27 that make the timing "less certain."
The delay suggests the cost of capturing the Vapor ODM growth is higher than anticipated. While operating cash burn improved for the full year, the upfront capital required to scale production means the company's $19.3 million cash pile will continue to face pressure before the business sustains itself.
Gross Margins Collapse
The most troubling reading in the print is unit economics. Gross margin compressed by 600 basis points year-over-year to just 6.3%. Even after adding back $431,902 in inventory impairments to find the clean figure, gross margin sat at roughly 8.0% — far below the 17-20% band the company operated in before the strategic pivot.
The collapse suggests that either the pricing required to win early Vapor ODM clients is highly aggressive, or the costs of ramping the new Malaysian lines are eroding profitability. Until margins clear the low double digits, the revenue growth is hollow.
Legacy Bad Debt Persists
Despite management's assertion that the cleanup of legacy cannabis customers is behind them, the financial toll continues. Credit loss expense was $9.2 million for the quarter, an increase from $8.6 million a year ago, consuming more than a third of the quarter's revenue.
While total accounts receivable have been cut in half year-over-year, the sustained write-offs indicate the remaining balance still carries high risk. The number to watch is the total bad debt provision next quarter; if it stays elevated, the balance sheet cleanup is not truly finished.
👓 Other Themes
Tariff Arbitrage as the Core Pitch
Ispire is leaning heavily into the 25% tariff advantage its fully operational Malaysian facility provides over Chinese exports to the U.S. This regulatory arbitrage is the primary hook for acquiring new mid-sized nicotine hardware clients on its Vapor ODM platform. The success of this strategy hinges on the geopolitical environment remaining fractured.
💲 Other KPIs
Fell 50.0% year-over-year from $39.6 million, reflecting the aggressive write-downs of legacy cannabis clients and a shift toward larger accounts.
Declined 53.5% year-over-year from $32.5 million, marking the physical realization of the company's strategic exit from the vertical.
Decreased slightly by $86,000 from the prior quarter. The narrow buffer leaves little room for execution error during the manufacturing scale-up.
🔮 Guidance
Withdrew the target issued last quarter to reach positive cash flow in the second half of 2026. Management cited first-quarter fiscal 2027 investments related to the Malaysia manufacturing facility as the cause for the delay.
❓ Key Questions
Magnitude of Factory Investments
What is the specific capital expenditure required for the Malaysia facility in Q1 FY27 that was significant enough to derail the second-half 2026 cash-flow positive target?
Margin Recovery Timeline
With the 25% tariff advantage now active in Malaysia, exactly when should investors expect gross margins to inflect back toward the mid-to-high teens?
Remaining AR Exposure
After recognizing $20.7 million in credit losses for the fiscal year, how much of the remaining $19.8 million in accounts receivable belongs to the legacy cannabis segment, and is it fully provisioned?